Interestingly, the majority of human breast cancer cell lines have lost their growth inhibitory responses to TGF-β in vitro[30], and only MCF10Ca1h cells have been definitively shown to retain tumor-suppressive responses to endogenous TGF-β in vivo[25]. This evidence concerns the gene TGFB1 and breast cancer.